Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-21-153907
Filing Date
2021-12-28
Accepted
2021-12-28 15:10:51
Documents
13
Period of Report
2021-12-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2136448d1_8ka.htm   iXBRL 8-K/A 28132
  Complete submission text file 0001104659-21-153907.txt   250014

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA huma-20211220.xsd EX-101.SCH 3683
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE huma-20211220_def.xml EX-101.DEF 26785
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE huma-20211220_lab.xml EX-101.LAB 37591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE huma-20211220_pre.xml EX-101.PRE 25403
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2136448d1_8ka_htm.xml XML 6234
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39532 | Film No.: 211524508
SIC: 2836 Biological Products, (No Diagnostic Substances)